GKV Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Buy
13,926
+34
+0.2% +$34.7K 5.39% 3
2026
Q1
$12.8M Sell
13,892
-679
-5% -$688K 4.79% 3
2025
Q4
$15.7M Sell
14,571
-160
-1% -$153K 5.86% 3
2025
Q3
$11.2M Sell
14,731
-198
-1% -$147K 4.44% 4
2025
Q2
$11.6M Sell
14,929
-25
-0.2% -$19.4K 5.15% 4
2025
Q1
$12.4M Sell
14,954
-508
-3% -$423K 6.14% 2
2024
Q4
$11.9M Buy
+15,462
New +$12.8M 4.87% 4

Other funds holding LLY

GKV Capital Management's LLY Position: Q2 2026 in Review

GKV Capital Management increased its Eli Lilly (LLY) stake by 0.24% in Q2 2026, buying an estimated $34.7K and bringing the position to 13,926 shares worth $16.7M. The position accounts for 5.39% of the portfolio, ranked #3.

GKV Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,303 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GKV Capital Management held 13,926 shares of Eli Lilly worth $16.7M as of Q2 2026.
  • GKV Capital Management bought 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 5.39% of GKV Capital Management's portfolio in Q2 2026, its #3 holding.
  • GKV Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GKV Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.